Adults 20 to 55, female only, with Menstrual Cycle or Exercise Treadmill. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
ST/HR Index (μV/Bpm)Primary· approximately 15 minutes each during the exercise treadmill tests performed at the early and late follicular phases of the menstrual cycle
The ST/HR index (μV/bpm) is automatically generated by the General Electronic GE Healthcare T2100-ST Treadmill \& CASE 6.73 Stress Test System at the end of the exercise treadmill test (ETT).
Group
Value
95% CI
Early Follicular Phase
1.2
± 0.82
Late Follicular Phase ETT
1.3
± 0.59
High-sensitive Cardiac Troponin T (ng/L) After ETTSecondary· approximately 1 hour each during the exercise treadmill tests performed at the early and late follicular phase of the menstrual cycle
High-sensitive cardiac troponin T levels (hs-cTnT) are measured by Roche kit before and after the exercise treadmill test both at the early and late follicular phases of the menstrual cycle.
Hs-cTnT before ETT
Group
Value
95% CI
Hs-cTnT Before and After ETT at the Early Follicular Phase
3.3
± 1.1
Hs-cTnT Before and After ETT at the Late Follicular Phase
3.6
± 1.4
Hs-cTnT after ETT
Group
Value
95% CI
Hs-cTnT Before and After ETT at the Early Follicular Phase
3.6
± 1.4
Hs-cTnT Before and After ETT at the Late Follicular Phase
3.6
± 2.5
Maximal Exercise Capacity (METs Score)Secondary· approximately 15 minutes each during the exercise treadmill tests performed at the early and late follicular phases of the menstrual cycle
The maximal exercise capacity (METs score) is automatically generated by the General Electronic GE Healthcare T2100-ST Treadmill \& CASE 6.73 Stress Test System at the end of the exercise treadmill test (ETT).
Group
Value
95% CI
Early Follicular Phase
10.0
± 1.9
Late Follicular Phase ETT
10.5
± 1.2
ST/HR Slope (μV/Bpm)Secondary· approximately 15 minutes each during the exercise treadmill tests performed at the early and late follicular phases of the menstrual cycle
ST/HR slope (μV/bpm) is automatically generated by the General Electronic GE Healthcare T2100-ST Treadmill \& CASE 6.73 Stress Test System at the end of the exercise treadmill test (ETT).
Group
Value
95% CI
Early Follicular Phase
1.8
± 1.2
Late Follicular Phase ETT
1.7
± 0.5
Maximal Horizontal or Down Slope ST Segment Depression (mm) During Exercise Treadmill TestSecondary· approximately 15 minutes each during the exercise treadmill tests performed at the early and late follicular phases of the menstrual cycle
Maximal horizontal or down slope ST segment depression (mm) is automatically generated by the General Electronic GE Healthcare T2100-ST Treadmill \& CASE 6.73 Stress Test System at the end of the exercise treadmill test (ETT).
Group
Value
95% CI
Early Follicular Phase
0.13
± 0.08
Late Follicular Phase ETT
0.15
± 0.08
Estrogen Levels Before the Exercise Treadmill Test.Secondary· approximately 1 hour before the exercise treadmill tests performed at the early and late follicular phases of the menstrual cycle
Estrogen levels are measured 1 hour before the exercise treadmill test (ETT) at the early and late follicular phases of the menstrual cycle.
Group
Value
95% CI
Estrogen Before the ETT at the Early Follicular Phase
33.3
22.3 – 63.3
Estrogen Before the ETT at the Late Follicular Phase
105.0
64.7 – 209.0
Sponsor's own description
False positive results are commonly observed in women after exercise treadmill test (ETT). The effects of menstrual cycle on the results of ETT in premenopausal women have not been clearly defined. Primary purpose of the study is to investigate the biological causes of false positive test results in the ETT in premenopausal women. Estrogen is known to have direct vasodilatory effects on coronary arteries. The early and late follicular phases of the menstrual cycle are characterized by low and high estrogen levels, respectively. The early follicular phase starts on the first day of the menstrual cycle and ends when estrogen begins to increase. It is characterised by increasing luteinizing hormone (LH) and follicle stimulating hormone (FSH) and low estrogen levels. The estrogen levels increase several folds in the late follicular phase. The hypothesis of the study is that ETT results will change at the early and late follicular phases of the menstrual cycle in premenstrual women. Premenopausal women between the ages of 20-55 years, who apply to the cardiology outpatient clinics of Göztepe City Hospital with chest pain. Patients who are ordered to have an ETT will be included in the study. ETT will be performed separately during the early and late follicular phases of the menstrual cycle.
The major finding of Exercise Treadmill Test is the ST segment deviation from the baseline. The ST segments are evaluated 60-80 ms after the J point. ECG positive Exercise Treadmill Test result was defined as ≥ 1 mm (0.1 mV) horizontal or downsloping ST depression in at least 3 consecutive beats.
Chest pain or inadequate hemodynamic response during Exercise Treadmill Tests are considered clinically positive Exercise Treadmill Test result. Tests that do not meet these criteria but show ST segment changes or had low diagnostic value due to baseline ECG changes are considered indeterminate Exercise Treadmill Test results.
Automated measurements and mathematical calculations are recorded in the Exercise Treadmill Test system (General Electronic GE Healthcare T2100-ST Treadmill \& CASE 6.73 Stress Test System). ST/HR index during Exercise Treadmill Tests at the early and late follicular phases of the menstrual cycle (µV/beats per minute (bpm)) will be compared in all patients. The secondary endpoints were ST/HR slope, maximum ST segment depression (mm), maximum exercise capacity, and the change in estrogen levels between the early and late follicular phases of the menstrual cycle. The study will also compare the concentrations of hs-cTnT before and after Exercise Treadmill Test. Exercise Treadmill Test results are evaluated by 2 different cardiologists and categorized as positive/indeterminate/negative Exercise Treadmill Test results. The concentrations of Hs-cTn are measured before and 15 minutes after Exercise Treadmill Test.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07248046 — Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
· recruiting
NCT07242209 — Sugammadex and Menstrual Cycle in Postoperative Nausea and Vomiting
· recruiting
NCT06771583 — Identification and Validation of Epigenetic Biomarkers of PMDD
· recruiting
NCT07258576 — Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise
· NA
· recruiting
NCT06892080 — Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study
· recruiting
Other Istanbul Medeniyet University trials
Trials by the same sponsor.
NCT07478380 — Transcutaneous pO₂ Monitoring in PICU
· recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co
· recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T
· NA
· not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care
· completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05985980.